AAAAAA

   
Results: 1-15 |
Results: 15

Authors: CHEN SH WANG Q MAO J KING I DUTSCHMAN GE GULLEN EA CHENG YC DOYLE TW
Citation: Sh. Chen et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF A SERIES OF ATED-2',3'-DIDEOXY-2',3'-DIDEHYDRO-(L)-NUCLEOSIDES, Bioorganic & medicinal chemistry letters, 8(13), 1998, pp. 1589-1594

Authors: DUTSCHMAN GE BRIDGES EG LIU SH GULLEN E GUO X KUKHANOVA M CHENG YC
Citation: Ge. Dutschman et al., METABOLISM OF -DIDEOXY-2',3'-DIDEHYDRO-BETA-L(-)-5-FLUROCYTIDINE AND ITS ACTIVITY IN COMBINATION WITH CLINICALLY APPROVED ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS BETA-D(-VITRO() NUCLEOSIDE ANALOGS IN), Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1799-1804

Authors: ZHU YL DUTSCHMAN GE LIU SH BRIDGES EG CHENG YC
Citation: Yl. Zhu et al., ANTI-HEPATITIS-B VIRUS ACTIVITY AND METABOLISM OF DIDEOXY-2',3'-DIDEHYDRO-BETA-L(-)-5-FLUOROCYTIDINE, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1805-1810

Authors: PAI RB PAI SB KUKHANOVA M DUTSCHMAN GE GUO X CHENG YC
Citation: Rb. Pai et al., TELOMERASE FROM HUMAN LEUKEMIA-CELLS - PROPERTIES AND ITS INTERACTIONWITH DEOXYNUCLEOSIDE ANALOGS, Cancer research, 58(9), 1998, pp. 1909-1913

Authors: LIN TS LUO MZ LIU MC ZHU YL GULLEN E DUTSCHMAN GE CHENG YC
Citation: Ts. Lin et al., DESIGN AND SYNTHESIS OF 2',3'-DIDEOXY-2',3'-DIDEHYDRO-BETA-L-CYTIDINE(BETA-L-D4C) AND 3'-DIDEOXY-2',3'-DIDEHYDRO-BETA-L-5-FLUOROCYTIDINE (BETA-L-FD4C), 2 EXCEPTIONALLY POTENT INHIBITORS OF HUMAN HEPATITIS-B VIRUS (HBV) AND POTENT INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)IN-VITRO, Journal of medicinal chemistry, 39(9), 1996, pp. 1757-1759

Authors: BRIDGES EG DUTSCHMAN GE GULLEN EA CHENG YC
Citation: Eg. Bridges et al., FAVORABLE INTERACTION OF BETA-L(-) NUCLEOSIDE ANALOGS WITH CLINICALLYAPPROVED ANTI-HIV NUCLEOSIDE ANALOGS FOR THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS, Biochemical pharmacology, 51(6), 1996, pp. 731-736

Authors: BRIDGES EG DUTSCHMAN GE GULLEN EA CHENG YC
Citation: Eg. Bridges et al., FAVORABLE INTERACTION OF BETA-L(-)NUCLEOSIDE ANALOGS WITH CLINICALLY APPROVED ANTI-HIV NUCLEOSIDE ANALOGS FOR THE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS (VOL 51, PG 731, 1996), Biochemical pharmacology, 51(10), 1996, pp. 1415-1415

Authors: LIN TS LUO MZ ZHU JL LIU MC ZHU YL DUTSCHMAN GE CHENG YC
Citation: Ts. Lin et al., SYNTHESIS OF A SERIES OF PURINE 2',3'-DIDEOXY-L-NUCLEOSIDE ANALOGS ASPOTENTIAL ANTIVIRAL AGENTS, Nucleosides & nucleotides, 14(8), 1995, pp. 1759-1783

Authors: LIN TS GUO X LUO MZ LIU MC ZHU YL DUTSCHMAN GE PAI SB LI MM CHENG YC
Citation: Ts. Lin et al., STUDIES OF THE PHARMACOKINETICS AND TOXICOLOGY OF 2',3'-DIDEOXY-BETA-L-5-FLUOROCYTIDINE (BETA-L-FDDC) AND 2',3'-DIDEOXY-BETA-L-CYTIDINE (BETA-L-DDC) IN-VIVO AND SYNTHESIS AND ANTIVIRAL EVALUATIONS OF 2',3'-DIDEOXY-BETA-L-5-AZACYTIDINE, Nucleosides & nucleotides, 14(3-5), 1995, pp. 619-625

Authors: PIRAS G DUTSCHMAN GE IM GJ PAN BC CHU SH CHENG YC
Citation: G. Piras et al., ACTION OF URACIL ANALOGS ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND ITS REVERSE-TRANSCRIPTASE, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 539-541

Authors: LIN TS LUO MZ LIU MC PAI SB DUTSCHMAN GE CHENG YC
Citation: Ts. Lin et al., SYNTHESIS AND BIOLOGICAL EVALUATION OF 2',3'-DIDEOXY-L-PYRIMIDINE NUCLEOSIDES AS POTENTIAL ANTIVIRAL AGENTS AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) AND HEPATITIS-B VIRUS (HBV), Journal of medicinal chemistry, 37(6), 1994, pp. 798-803

Authors: PAN BC CHEN HC PIRAS G DUTSCHMAN GE ROWE EC CHENG YC CHU SH
Citation: Bc. Pan et al., SYNTHESIS AND ANTI-HIV-1 ACTIVITIES OF 6-ARYLTHIO AND 6-ARYLSELENOACYCLONUCLEOSIDES, Journal of heterocyclic chemistry, 31(1), 1994, pp. 177-185

Authors: YEN Y GRILL SP DUTSCHMAN GE CHANG CN ZHOU BS CHENG YC
Citation: Y. Yen et al., CHARACTERIZATION OF A HYDROXYUREA-RESISTANT HUMAN KB CELL-LINE WITH SUPERSENSITIVITY TO 6-THIOGUANINE, Cancer research, 54(14), 1994, pp. 3686-3691

Authors: LIN TS LUO MZ LIU MC PAI SB DUTSCHMAN GE CHENG YC
Citation: Ts. Lin et al., ANTIVIRAL ACTIVITY OF 2',3'-DIDEOXY-BETA-L-5-FLUOROCYTIDINE (BETA-L-FDDC) AND 2',3'-DIDEOXY-BETA-L-CYTIDINE (BETA-L-DDC) AGAINST HEPATITIS-B VIRUS AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO, Biochemical pharmacology, 47(2), 1994, pp. 171-174

Authors: MELLORS JW DUTSCHMAN GE IM GJ TRAMONTANO E WINKLER SR CHENG YC
Citation: Jw. Mellors et al., INVITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN IMMUNODEFICIENCY VIRUS-1 RESISTANT TO NONNUCLEOSIDE INHIBITORS OF REVERSE-TRANSCRIPTASE, Molecular pharmacology, 41(3), 1992, pp. 446-451
Risultati: 1-15 |